Search Contract Opportunities

Sumatriptan Succinate Tablets   3

ID: SPE2D223R0003 • Type: Solicitation • Match:  90%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
Does this contract have any security clearance requirements?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

Posted: Feb. 3, 2023, 2:52 p.m. EST

Amendment 0003 issued February 03,2023 to extend the closing date from February 03, 2023 3:00 PM to February 17, 2023 3:00 PM EST.

Amendment 0002 issued January 04,2023 to extend the closing date from January 20, 2023 3:00 PM to February 03, 2023 3:00 PM EST.

Amemdment 0001 issued December 15, 2022 to incorporate statement, DOD Class Deviation 2023-O0001, Verification of Eligibility of Small Business Joint Ventures, into solicitation.

SPE2D2-23-R-0003 SUMATRIPTAN SUCCINATE TABLET SOLICITATION

Posted: Jan. 4, 2023, 2:26 p.m. EST
Posted: Dec. 15, 2022, 11:11 a.m. EST
Posted: Dec. 14, 2022, 9:39 a.m. EST
Background
The Defense Logistics Agency (DLA) Troop Support, Directorate of Medical Materiel provides pharmaceutical products for the Department of Defense (DoD) to its customers through its Pharmaceutical Prime Vendor program. The Department of Veterans Affairs (VA) provides pharmaceutical products to its customers as well as the Indian Health Service (IHS) and the Bureau of Prisons (BoP) through the VA Pharmaceutical Prime Vendor Program. Hereafter these programs are collectively referred to as the “PPV.” A prime vendor is an independent business concern that functions as a purchaser's primary source for specified classes of products and is responsible for the delivery of goods produced by various suppliers.
As a part of the Pharmaceutical Prime Vendor Program, this solicitation will establish a national contract for the items listed in the schedule. The PPV Programs consist of separate contracts which establish the fees for the distribution of pharmaceutical products that are distributed through the PPV Programs on Federal Government (i.e., Federal Supply Schedules, DLA National Contracts) contracts. The awardee consents to allow VA and DLA Troop Support Prime Vendors to distribute the listed products in the schedule.

Work Details
The contract resulting from this solicitation will establish a national supply source to provide pharmaceutical products for purchase through the PPV programs. The annual usage for DLA, VA, BoP and IHS customers served through the Prime Vendor Programs is estimated in the Schedule of Supplies. The objective of the contract is to ensure availability and consistency of product and to obtain volume-based, committed use pricing.
Ordering activities will purchase the selected contractor’s product for the items listed in the Schedule of Supplies section of this Solicitation through the DLA or VA PPV contractors except when: (1) the contracted items is/are unavailable to meet the needs of or (2) an alternate is requested by the prescribing healthcare provider, or (3) the contract holder does not participate in third party reimbursement programs, such as the Medicaid Rebate Program (#3 applies to IHS requirements only).

Period of Performance
The contract resulting herein will be for a one year base period and include four option years for a maximum possible term of five years.

Place of Performance
The complete order quantity shall be delivered to the PPV contractors within 15 calendar days after receipt of order.

Overview

Response Deadline
Feb. 17, 2023, 3:00 p.m. EST (original: Jan. 20, 2023, 3:00 p.m. EST) Past Due
Posted
Dec. 14, 2022, 9:39 a.m. EST (updated: Feb. 3, 2023, 2:52 p.m. EST)
Set Aside
None
Place of Performance
Not Provided
Source

Current SBA Size Standard
1300 Employees
Pricing
Likely Fixed Price
Est. Level of Competition
Average
On 12/14/22 DLA Troop Support - Medical issued Solicitation SPE2D223R0003 for Sumatriptan Succinate Tablets due 2/17/23. The opportunity was issued full & open with NAICS 325412 and PSC 6505.
Primary Contact
Name
Phyllis Daraio   Profile
Phone
(215) 737-7941

Documents

Posted documents for Solicitation SPE2D223R0003

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Opportunity Lifecycle

Procurement notices related to Solicitation SPE2D223R0003

Award Notifications

Agency published notification of awards for Solicitation SPE2D223R0003

IDV Awards

Indefinite delivery vehicles awarded through Solicitation SPE2D223R0003

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Solicitation SPE2D223R0003

Similar Active Opportunities

Open contract opportunities similar to Solicitation SPE2D223R0003

Additional Details

Source Agency Hierarchy
DEPT OF DEFENSE > DEFENSE LOGISTICS AGENCY (DLA) > TROOP SUPPORT MEDICAL > DLA TROOP SUPPORT
FPDS Organization Code
97AS-SPE2D2
Source Organization Code
500045947
Last Updated
Feb. 3, 2023
Last Updated By
phyllis.daraio@dla.mil
Archive Date
Jan. 20, 2029